Swedish Orphan Biovitrum AB (0MTD)
LSE
465.20
+13.00 (+2.87%)
Closed
Aug 25, 2026
Day's Range
455.00469.60
52 wk Range
263.20486.40
Financial Statements - 0MTD - Swedish Orphan Biovitrum AB
Revenue
28.23B▲ 8.5%
Net Income
476.00M▼ 87.7%Net Margin 1.7%
EBITDA
10.93B▲ 17.2%
Free Cash Flow
5.41B▲ 23.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 28.23B | 26.02B | 22.12B | 18.79B | 15.52B | 15.26B |
| Cost of Goods | 6.25B | 5.78B | 4.99B | 4.77B | 3.48B | 3.22B |
| Gross Profit | 21.98B | 20.24B | 17.12B | 14.01B | 12.04B | 12.03B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 922M | 5.61B | 4.06B | 3.84B | 3.78B | 4.46B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 34M | 4.40B | 2.95B | 3.32B | 3.29B | 4.21B |
| Income Tax | -442M | 528M | 546M | 683M | 616M | 972M |
| Net Income | 476M | 3.87B | 2.40B | 2.63B | 2.67B | 3.24B |
| EPS Basic | 1.39 | 11.37 | 7.47 | 8.52 | 8.672958 | 10.51644 |
| EPS Diluted | 1.37 | 11.24 | 7.39 | 8.44 | 8.6252 | 10.411371 |
| Basic Shares Outstanding | 344.29M | 341.72M | 322.65M | 309.47M | 308.89M | 308.48M |
| Diluted Shares Outstanding | 344.29M | 341.72M | 322.65M | 309.47M | 308.89M | 308.48M |
| Ebit | 836M | 5.64B | 4.06B | 3.77B | 3.71B | 4.67B |
| Ebitda | 10.93B | 9.32B | 7.26B | 6.05B | 5.77B | 6.29B |
| Net Income Continuous Operations | 34M | 4.40B | 2.95B | 3.32B | 3.29B | 4.21B |
| Minority Interests | 2M | 6M | 0 | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
